TLX250-CDx Indication Expansion: Preliminary Data Presented at EANM ...Middle East

PR Newswire - News
TLX250-CDx Indication Expansion: Preliminary Data Presented at EANM
OPALESCENCE Phase II feasibility study of TLX250-CDx in patients with triple-negative breast cancer – early results suggest potential to detect carbonic anhydrase IX (CAIX) expression, theranostic potential in this difficult to treat disease. PERTINENCE Early Phase I feasibility study of...

Hence then, the article about tlx250 cdx indication expansion preliminary data presented at eanm was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( TLX250-CDx Indication Expansion: Preliminary Data Presented at EANM )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News